Who funds autoimmune disease research?

We count 135 funded autoimmune disease projects, active between 2019 and 2034, from 5 funders. The most came from EU · ERC (43 projects), Wellcome (32 projects) and EU · MSCA (16 projects). The median award is $2.5M, across the 125 of 135 projects that list an amount.

Funded projects

135

Funders

5

Median award

$2.5M

Open calls now

2

Top funders of autoimmune disease research

Projects whose title or summary mentions autoimmune disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open autoimmune disease funding calls

2 open calls mention autoimmune disease today.

• Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease
  U.S. Department of Health and Human Services – ARPA-H (SBIR/STTR)Not specifiedDeadline: September 30, 2027 ·
• Immune Tolerance Network (UM1 Clinical Trial Required)
  National Institutes of HealthNot specifiedDeadline: January 29, 2027 ·

Forecast: announced, not open yet

1 forecast call on autoimmune disease. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastImmune Drivers of Autoimmune Disease
  National Institutes of HealthNot specifiedExpected to open February 26, 2027

Funded autoimmune disease projects

A sample, latest start first, at most three per program.

• Harmful R-loops: from molecular mechanisms to human disease
  Wellcome · £2,037,970 · ends 2034
• Myeloid Inhibitory C-type lectin-like receptor (MICL, CLEC12A) – a central regulator of immunity
  Wellcome · £4,652,166 · ends 2034
• A mouse to human approach to trace stem cell dynamics in development and cancer of salivary glands
  Wellcome · £2,243,044 · ends 2034
• Center for Rational HCV Vaccine Design & Evaluation
  NIH · NIAID · $3,282,170 · ends 2031
• On-Demand In Vivo Reprogramming of Endogenous Extracellular Vesicles for Targeted Biotherapeutic Delivery
  UKRI · BBSRC · £1,695,127 · ends 2031
• Discovery of Pathways and Molecular Mediators of Early T1D Pathogenesis using Spatial Multi-Omics
  NIH · NIDDK · $3,112,201 · ends 2030
• Transcriptional and post-transcriptional regulation of human Treg identity and function
  NIH · NIAID · $3,601,712 · ends 2030
• The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository)
  NIH · NIA · $5,110,455 · ends 2029
• Interferon Signaling in the T1D Islet Microenvironment
  NIH · NIDDK · $3,546,985 · ends 2029
• Functional and Mechanistic Characterization of Lupus Susceptibility
  NIH · NIAID · $3,364,935 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “autoimmune”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.